You are here

  • Home
  • Archive
  • Volume 83, Issue 1
  • LHRH analogue and growth hormone did not improve the final height of a patient with juvenile hypothyroidism accompanied by precocious puberty

Article Text

Article menu
Download PDFPDF
Letters to the editor
LHRH analogue and growth hormone did not improve the final height of a patient with juvenile hypothyroidism accompanied by precocious puberty
  1. RIKA MIYAZAKI,
  2. NAOMI YANAGAWA,
  3. HIROHIKO HIGASHINO,
  4. YOHNOSUKE KOBAYASHI
  1. Department of Paediatrics, Kansai Medical University
  2. 10–15 Fumizonocho, Moriguchi
  3. Osaka 570-8506, Japan

https://doi.org/10.1136/adc.83.1.87e

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Editor,—We report an 11 years 8 months old girl with juvenile hypothyroidism and precocious puberty who failed to respond to thyroxine, growth hormone, and luteinising hormone releasing hormone (LHRH) analogue. The patient was considered to be hypothyroid for about two years before the therapy was started. She had a very low serum thyroxine concentration, a height SD score of −3 SD, and a bone age of 10 years 3 months. Her pubertal development was graded as Tanner stage IV of breasts and Tanner stage II of pubic hair. Her menarche occurred at the age of 10 years 3 months. The enlarged …

    View Full Text

    Linked Articles